Zebrafish models of Tauopathy

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Tauopathies are incurable neurodegenerative diseases characterized by Tau protein aggregation.
• Current research lacks sufficient models for comprehensive genetic and chemical screening.
• Zebrafish offer a unique platform for in vivo imaging and high-throughput screening.

Purpose of the Study:

• To evaluate the potential of zebrafish as a model for studying tauopathies.
• To explore the utility of zebrafish for identifying novel therapeutic targets and compounds.
• To leverage zebrafish's genetic tractability and imaging capabilities for tauopathy research.

Main Methods:

• Development of novel transgenic zebrafish lines expressing human Tau (wild-type and mutant).
• Analysis of disease-relevant Tau changes in zebrafish neurons, including phosphorylation and aggregation.
• Assessment of neuronal dysfunction and death in response to Tau transgene expression.

Main Results:

• Transgenic zebrafish exhibit disease-relevant Tau modifications (relocalization, hyperphosphorylation, aggregation).
• Preliminary evidence indicates Tau expression can lead to neuronal dysfunction and death in zebrafish.
• Zebrafish models show promise for studying tauopathy pathogenesis and progression.

Conclusions:

• Zebrafish represent a viable and promising model system for tauopathy research.
• Further studies are needed to fully characterize zebrafish tauopathy phenotypes and develop screening assays.
• Zebrafish models can accelerate the discovery of disease-modifying therapies for tauopathies.